This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Imatinib responsive erythrocytosis in a patient with FIP1L1:PDGFRA rearranged myeloid neoplasm with hypereosinophilia – Another manifestation of a stem cell neoplasm. (October 2022)
Record Type:
Journal Article
Title:
Imatinib responsive erythrocytosis in a patient with FIP1L1:PDGFRA rearranged myeloid neoplasm with hypereosinophilia – Another manifestation of a stem cell neoplasm. (October 2022)
Main Title:
Imatinib responsive erythrocytosis in a patient with FIP1L1::PDGFRA rearranged myeloid neoplasm with hypereosinophilia – Another manifestation of a stem cell neoplasm